Table of contents

Original article

• Anti-Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosis (1 September, 2001) Free

  E Caballero, M-E Drobnic, M-T Pérez, J-M Manresa, A Ferrer, R Orriols
• Effects of inhaled salbutamol in exercising non-asthmatic athletes (1 September, 2001) Free

  C Goubault, M-C Perault, E Leleu, S Bouquet, P Legros, B Vandel, A Denjean
• Airway function at one year: association with premorbid airway function, wheezing, and maternal smoking (1 September, 2001) Free

  C Dezateux, J Stocks, A M Wade, I Dundas, M E Fletcher
• Changing patterns of hospital admission for asthma, 1981–97 (1 September, 2001) Free

  D S Morrison, P McLoone
• Reference values of interrupter respiratory resistance in healthy preschool white children (1 September, 2001) Free

  E Lombardi, P D Sly, G Concutelli, E Novembre, G Veneruso, G Frongia, R Bernardini, A Vierucci
• Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway (1 September, 2001) Free

  R K Turlej, L Fiévez, C F Sandersen, S Dogné, N Kirschvink, P Lekeux, F Bureau
• Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study (1 September, 2001) Free

  M Pelkonen, I-L Notkola, H Tukiainen, M Tervahauta, J Tuomilehto, A Nissinen
• Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome (1 September, 2001) Free

  P K Plant, J L Owen, M W Elliott
• Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease (1 September, 2001) Free

  J Hadcroft, P M A Calverley
• Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations (1 September, 2001) Free

  M A Dentener, E C Creutzberg, A M W J Schols, A Mantovani, C van‘t Veer, W A Buurman, E F M Wouters
• Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use (1 September, 2001) Free

  G Popescu, M Latham, V Allgar, M W Elliott